Assessment of iatrogenic transmission of HCV in southern Italy: Was the cause the Salk polio vaccination?

Journal of Medical Virology

Volumn 70, Issue 1, 2003, Pages 49-50

  Montella, Maurizio ^a,b   Crispo, Anna ^a   Grimaldi, Maria ^a   Tridente, Vincenzo ^a   Fusco, Mario ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Cancer Registry ^*  (Italy)

Author keywords

Hepatitis C virus infection; Iatrogenic transmission; Parenteral Salk vaccine; Southern Italy

Indexed keywords

HEPATITIS C ANTIBODY; INACTIVATED VACCINE; POLIOMYELITIS VACCINE; VIRUS VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS; PREVALENCE; SYRINGE; VACCINATION; VIRUS HEPATITIS;

ADULT; COHORT EFFECT; DRUG CONTAMINATION; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IATROGENIC DISEASE; INFUSIONS, PARENTERAL; ITALY; MALE; MIDDLE AGED; POLIOVIRUS VACCINES; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS C VIRUS;

EID: 0037401852     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10362     Document Type: Article

References (11)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562.
2. Austin GE, Jensen B, Leete J, De L'Aune W, Bhatnagar J, Racine M, Braun JE. 2000. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. Am J Med Sci 319:353-359.
3. Botte C, Janot C. 1996. Epidemiology of HCV infection in the general population and in blood transfusion. Nephrol Dial Transplant 11(suppl 4):19-21.
4. Di Stefano R, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, Pomara G, Craxi A. 2002. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatronic transmission. J Med Virol 67:339-344.
5. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Koby T. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
6. Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafa L, Romano N. 2002. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 94:1712-1718.
7. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Condili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Foca A, Piazza M. 1997. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population. A community-based survey in southern Italy. Hepatology 26:1006-1011.
8. Harsch HH, Pankiewicz J, Bloom AS, Rainey C, Cho JK, Sperry L, Stein EA. 2000. Hepatitis C virus infection in a cocaine users: a silent epidemic. Community Mental Health J 36:225-233.
9. Laur GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
10. Montella M, Bidoli E, De Marco MR, Iannuzzo MT, Fusco M, Pamlombini R, Franceschi S, Monfardini S. 1998. High mortality rates from liver cancer in the urban area of Campania Region: prevalence of hepatitis and sociodemographic factors. Oncol Rep 5:165-169.
11. Trepo C, Pradat P. 1999. Hepatitis C virus infection in Western Europe. J Hepatol 31(suppl 1):80-83.